Pharmaceutical Desiccants Market Research Report Forecast to 2030

PUBLISHED: December 2, 2023

PAGES: 128 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Pharmaceutical Desiccants Market is anticipated to register a healthy CAGR of 4.77% during the review period. Pharmaceutical desiccants are specialists or substances used to retain dampness and keep a dry climate in pharmaceutical bundling. They are essential in forestalling the debasement of pharmaceutical items that are delicate to dampness or inclined to dampness actuated disintegration.

The geriatric populace is expanding across the globe, with varieties by country. The geriatric populace is projected to become one of the main social changes of the twenty-first 100 years, with suggestions for practically every one of the areas of society, including monetary and work markets; interest for labor and products, like lodging, transportation, and social security; as well as intergenerational ties and family structures.

The pharmaceutical business assumes a unique part in creating immunizations and prescriptions to diminish the dangers and treat serious sicknesses and all the while work on the individual fulfillment of people. The business has a vital commitment to growing mechanically progressed items through creative research to fulfill the developing need. All around the world, pharmaceutical administrations have become quite possibly of the quickest developing portion - both regarding pay and business. Because of the reinforcing administrations of the pharmaceutical business across the globe, the interest in pharmaceuticals is supposed to pick up speed in the approaching future.

Market Segmentation

The Pharmaceutical Desiccants Market segmentation, based on type has been segmented as silica gel, activated, carbonclay desiccant, molecular sieves.

The Pharmaceutical Desiccants Market segmentation, based on application, the market is segmented as tablets, API's, capsules, and nutraceutical product packaging.

Regional Insights

The sizable pharmaceutical desiccants industry in North America is probably going to make the region the biggest extending worldwide market for pharmaceutical desiccants. The nations of the US and Canada structure the market for pharmaceutical desiccant in the North American region. The US FDA is viewed as perhaps of the best administrative body on the planet. Item endorsements are fast, with a middle season of roughly 13 months. Then again, the nation's free valuing strategy is a significant advantage to the pharmaceutical desiccant industry. Moreover, the solid pharmaceutical assembling base in the region, because of strong unofficial laws and high Research and development consumption, bodes drives the development of the market. In addition, the developing geriatric populace will drive the pharmaceutical desiccants market. For example, as indicated by Organization on Maturing (AoA) (part of the Organization for Local area Living) a working division of the U.S. Branch of Wellbeing and Human Administrations, in the U.S. the populace age 65 and more seasoned numbered 54.1 million out of 2019 which addresses 16% of the complete us populace.

Major Players

Key Companies in the Pharmaceutical Desiccants Market includes I. Du Pont De Nemours and Company (US), Filtration Group Corporation (US), Sanner GmbH (Germany), Clariant Global (Switzerland), CSP Technologies Inc (US), Capitol Scientific Inc (US), Desiccare Inc (US), R. Grace & Company (US), Desican Inc (Canada), and Oker Chemie GmbH (Germany).

Product Code: MRFR/CnM/2838-CR

TABLE OF CONTENTS

1 Executive Summary

1.1 MARKET ATTRACTIVENESS ANALYSIS
- 1.1.1 GLOBAL Pharmaceutical Desiccants Market, BY TYPE
- 1.1.2 GLOBAL Pharmaceutical Desiccants Market, BY END USE
- 1.1.3 GLOBAL Pharmaceutical Desiccants Market, BY Region

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 TOP-DOWN And BOTTOM-Up APPROACH
3.6 FORECAST MODEL
3.7 LIST OF ASSUMPTIONS & LIMITATIONS

4 Market Dynamics

4.1 Overview
4.2 Drivers
- 4.2.1 Growing Geriatric Population Across The Globe
- 4.2.2 Expanding Pharmaceutical Industry
- 4.2.3 Growth Of The Packaging Industry
4.3 Restraints
- 4.3.1 Stringent Regulations And High Cost Of The Finished Product
4.4 Opportunities
- 4.4.1 Increasing Demand For Pharmaceutical Desiccants In Emerging Economies
4.5 Challenge
- 4.5.1 Rising Customer Expectations In The Indian Market

5 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY TYPE

5.1 OVERVIEW
- 5.1.1 PHARMACEUTICAL DESICCANTS: MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030
- 5.1.2 PHARMACEUTICAL DESICCANTS: MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030
5.2 SILICA GEL
- 5.2.1 SILICA GEL: MARKET ESTIMATES & FORECAST BY Region,2019-2030
5.3 ACTIVATED
- 5.3.1 ACTIVATED: MARKET ESTIMATES & FORECAST BY Region,2019-2030
5.4 CARBONCLAY DESICCANT
- 5.4.1 CARBONCLAY DESICCANT: MARKET ESTIMATES & FORECAST BY Region,2019-2030
5.5 Molecular Sieves
- 5.5.1 Molecular Sieves: MARKET ESTIMATES & FORECAST BY Region,2019-2030

6 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY END-USE

6.1 OVERVIEW
- 6.1.1 PHARMACEUTICAL DESICCANTS: MARKET ESTIMATES & FORECAST BY END-USE, 2019-2030
- 6.1.2 PHARMACEUTICAL DESICCANTS: MARKET ESTIMATES & FORECAST BY END-USE, 2019-2030
6.2 Tablets
- 6.2.1 Tablets: MARKET ESTIMATES & FORECAST BY Region,2019-2030
6.3 API's
- 6.3.1 API's: MARKET ESTIMATES & FORECAST BY Region,2019-2030
6.4 Capsules
- 6.4.1 Capsules: MARKET ESTIMATES & FORECAST BY Region,2019-2030
6.5 Nutraceutical Product Packaging
- 6.5.1 Nutraceutical Product Packaging: MARKET ESTIMATES & FORECAST BY Region,2019-2030

7 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION

7.1 OVERVIEW
7.2 NORTH AMERICA
- 7.2.1 US
- 7.2.2 Canada
7.3 EUROPE
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 FRANCE
- 7.3.4 SPAIN
- 7.3.5 ITALY
- 7.3.6 RUSSIA
- 7.3.7 POLAND
- 7.3.8 REST OF EUROPE
7.4 Asia-Pacific
- 7.4.1 China
- 7.4.2 JAPAN
- 7.4.3 India
- 7.4.4 SOUTH KOREA
- 7.4.5 Rest Of Asia-Pacific
7.5 Latin AMERICA
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest Of Latin America
7.6 Middle East & Africa
- 7.6.1 GCC COUNTRIES
- 7.6.2 South Africa
- 7.6.3 TURKEY
- 7.6.4 Rest Of The Middle East & Africa

8 Competitive Landscape

8.1 Introduction
8.2 Market Strategy Analysis
8.3 Key Developments & Growth Strategies
8.4 Competitive Benchmarking

9 COMPANY PROFILES

9.1 Dupont De Nemours, Inc.
- 9.1.1 COMPANY OVERVIEW
- 9.1.2 FINANCIAL OVERVIEW
- 9.1.3 PRODUCTS OFFERED
- 9.1.4 KEY DEVELOPMENTS
- 9.1.5 SWOT ANALYSIS
- 9.1.6 KEY STRATEGIES
9.2 Filtration Group Corporation
- 9.2.1 COMPANY OVERVIEW
- 9.2.2 FINANCIAL OVERVIEW
- 9.2.3 PRODUCTS OFFERED
- 9.2.4 KEY DEVELOPMENTS
- 9.2.5 SWOT ANALYSIS
- 9.2.6 KEY STRATEGIES
9.3 Sanner GmbH
- 9.3.1 COMPANY OVERVIEW
- 9.3.2 FINANCIAL OVERVIEW
- 9.3.3 PRODUCTS OFFERED
- 9.3.4 KEY DEVELOPMENTS
- 9.3.5 SWOT ANALYSIS
- 9.3.6 KEY STRATEGIES
9.4 Clariant
- 9.4.1 COMPANY OVERVIEW
- 9.4.2 FINANCIAL OVERVIEW
- 9.4.3 PRODUCTS OFFERED
- 9.4.4 KEY DEVELOPMENTS
- 9.4.5 SWOT ANALYSIS
- 9.4.6 KEY STRATEGIES
9.5 CSP Technologies, Inc.
- 9.5.1 COMPANY OVERVIEW
- 9.5.2 FINANCIAL OVERVIEW
- 9.5.3 PRODUCTS OFFERED
- 9.5.4 KEY DEVELOPMENTS
- 9.5.5 SWOT ANALYSIS
- 9.5.6 KEY STRATEGIES
9.6 Capitol Scientific, Inc.
- 9.6.1 COMPANY OVERVIEW
- 9.6.2 FINANCIAL OVERVIEW
- 9.6.3 PRODUCTS OFFERED
- 9.6.4 KEY DEVELOPMENTS
- 9.6.5 SWOT ANALYSIS
- 9.6.6 KEY STRATEGIES
9.7 Desiccare, Inc.
- 9.7.1 COMPANY OVERVIEW
- 9.7.2 FINANCIAL OVERVIEW
- 9.7.3 PRODUCTS OFFERED
- 9.7.4 KEY DEVELOPMENTS
- 9.7.5 SWOT ANALYSIS
- 9.7.6 KEY STRATEGIES
9.8 W. R. Grace & Co
- 9.8.1 COMPANY OVERVIEW
- 9.8.2 FINANCIAL OVERVIEW
- 9.8.3 PRODUCTS OFFERED
- 9.8.4 KEY DEVELOPMENTS
- 9.8.5 SWOT ANALYSIS
- 9.8.6 KEY STRATEGIES
9.9 Desican Inc.
- 9.9.1 COMPANY OVERVIEW
- 9.9.2 FINANCIAL OVERVIEW
- 9.9.3 PRODUCTS OFFERED
- 9.9.4 KEY DEVELOPMENTS
- 9.9.5 SWOT ANALYSIS
- 9.9.6 KEY STRATEGIES
9.10 Oker-Chemie GmbH
- 9.10.1 COMPANY OVERVIEW
- 9.10.2 FINANCIAL OVERVIEW
- 9.10.3 PRODUCTS OFFERED
- 9.10.4 KEY DEVELOPMENTS
- 9.10.5 SWOT ANALYSIS
- 9.10.6 KEY STRATEGIES

10 APPENDIX

10.1 REFERENCES
10.2 RELATED REPORTS

Product Code: MRFR/CnM/2838-CR

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PHARMACEUTICAL DESICCANTS MARKET ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 3 PHARMACEUTICAL DESICCANTS MARKET ESTIMATES & FORECAST, BY TYPE, 2019-2030 (TONS)
TABLE 4 SILICA GEL MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 5 SILICA GEL MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (TONS)
TABLE 6 ACTIVATED MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 7 ACTIVATED MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (TONS)
TABLE 8 CARBONCLAY DESICCANT MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 9 CARBONCLAY DESICCANT MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (TONS)
TABLE 10 MOLECULAR SIEVES MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 11 MOLECULAR SIEVES MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (TONS)
TABLE 12 PHARMACEUTICAL DESICCANTS MARKET ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 13 PHARMACEUTICAL DESICCANTS MARKET ESTIMATES & FORECAST, BY END-USE, 2019-2030 (TONS)
TABLE 14 TABLETS MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 15 TABLETS MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (TONS)
TABLE 16 API'S MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 17 API'S MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (TONS)
TABLE 18 CAPSULES MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 19 CAPSULES MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (TONS)
TABLE 20 NUTRACEUTICAL PRODUCT PACKAGING MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 21 NUTRACEUTICAL PRODUCT PACKAGING MARKET ESTIMATES & FORECAST, BY REGION, 2019-2030 (TONS)
TABLE 22 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION, 2019-2030 (USD THOUSAND)
TABLE 23 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION, 2019-2030 (TONS)
TABLE 24 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND)
TABLE 25 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (TONS)
TABLE 26 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 27 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 28 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 29 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 30 US: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 31 US: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 32 US: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 33 US: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 34 CANADA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 35 CANADA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 36 CANADA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 37 CANADA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 38 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND)
TABLE 39 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (TONS)
TABLE 40 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 41 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 42 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 43 EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 44 GERMANY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 45 GERMANY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 46 GERMANY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 47 GERMANY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 48 UK: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 49 UK: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 50 UK: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 51 UK: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 52 FRANCE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 53 FRANCE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 54 FRANCE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 55 FRANCE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 56 SPAIN: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 57 SPAIN: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 58 SPAIN: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 59 SPAIN: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 60 ITALY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 61 ITALY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 62 ITALY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 63 ITALY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 64 RUSSIA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 65 RUSSIA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 66 RUSSIA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 67 RUSSIA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 68 POLAND: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 69 POLAND: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 70 POLAND: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 71 POLAND: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 72 REST OF EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 73 REST OF EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 74 REST OF EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 75 REST OF EUROPE: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 76 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND)
TABLE 77 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (TONS)
TABLE 78 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 79 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 80 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 81 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 82 CHINA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 83 CHINA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 84 CHINA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 85 CHINA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 86 JAPAN: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 87 JAPAN: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 88 JAPAN: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 89 JAPAN: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 90 INDIA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 91 INDIA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 92 INDIA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 93 INDIA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 94 SOUTH KOREA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 95 SOUTH KOREA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 96 SOUTH KOREA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 97 SOUTH KOREA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 98 REST OF ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 99 REST OF ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 100 REST OF ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 101 REST OF ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 102 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND)
TABLE 103 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (TONS)
TABLE 104 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 105 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 106 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 107 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 108 BRAZIL: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 109 BRAZIL: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 110 BRAZIL: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 111 BRAZIL: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 112 MEXICO: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 113 MEXICO: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 114 MEXICO: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 115 MEXICO: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 116 ARGENTINA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 117 ARGENTINA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 118 ARGENTINA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 119 ARGENTINA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 120 REST OF LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 121 REST OF LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 122 REST OF LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 123 REST OF LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 124 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (USD THOUSAND)
TABLE 125 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2019-2030 (TONS)
TABLE 126 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 127 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 128 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 129 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 130 GCC COUNTRIES: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 131 GCC COUNTRIES: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 132 GCC COUNTRIES: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 133 GCC COUNTRIES: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 134 SOUTH AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 135 SOUTH AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 136 SOUTH AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 137 SOUTH AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 138 TURKEY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 139 TURKEY: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 140 TURKEY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 141 TURKEY: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 142 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (USD THOUSAND)
TABLE 143 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019-2030 (TONS)
TABLE 144 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (USD THOUSAND)
TABLE 145 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019-2030 (TONS)
TABLE 146 KEY DEVELOPMENTS & GROWTH STRATEGIES
TABLE 147 DUPONT DE NEMOURS, INC.: PRODUCTS OFFERED
TABLE 148 FILTRATION GROUP CORPORATION: PRODUCTS OFFERED
TABLE 149 FILTRATION GROUP CORPORATION: KEY DEVELOPMENTS
TABLE 150 SANNER GMBH: PRODUCTS OFFERED
TABLE 151 SANNER GMBH: KEY DEVELOPMENTS
TABLE 152 CLARIANT: PRODUCTS OFFERED
TABLE 153 CLARIANT: KEY DEVELOPMENTS
TABLE 154 CSP TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 155 CSP TECHNOLOGIES, INC.: KEY DEVELOPMENTS
TABLE 156 CAPITOL SCIENTIFIC, INC.: PRODUCTS OFFERED
TABLE 157 DESICCARE, INC.: PRODUCTS OFFERED
TABLE 158 W. R. GRACE & CO: PRODUCTS OFFERED
TABLE 159 DESICAN INC.: PRODUCTS OFFERED
TABLE 160 OKER-CHEMIE GMBH: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL PHARMACEUTICAL DESICCANTS MARKET, 2020
FIGURE 3 GLOBAL PHARMACEUTICAL DESICCANTS MARKET ANALYSIS, BY TYPE
FIGURE 4 GLOBAL PHARMACEUTICAL DESICCANTS MARKET ANALYSIS, BY END USE
FIGURE 5 GLOBAL PHARMACEUTICAL DESICCANTS MARKET ANALYSIS, BY REGION
FIGURE 6 GLOBAL PHARMACEUTICAL DESICCANTS MARKET: MARKET STRUCTURE
FIGURE 7 RESEARCH PROCESS OF MRFR
FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE PHARMACEUTICAL DESICCANTS MARKET
FIGURE 9 DRIVER IMPACT ANALYSIS
FIGURE 10 RESTRAINT IMPACT ANALYSIS
FIGURE 11 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019 TO 2030 (USD THOUSAND)
FIGURE 12 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2019 TO 2030 (TONS)
FIGURE 13 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019 TO 2030 (USD THOUSAND)
FIGURE 14 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2019 TO 2030 (TONS)
FIGURE 15 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION, 2019-2030 (USD THOUSAND)
FIGURE 16 GLOBAL PHARMACEUTICAL DESICCANTS MARKET, BY REGION, 2019-2030 (TONS)
FIGURE 17 NORTH AMERICA: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE)
FIGURE 18 EUROPE: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE)
FIGURE 19 ASIA-PACIFIC: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE)
FIGURE 20 LATIN AMERICA: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE)
FIGURE 21 MIDDLE EAST & AFRICA: PHARMACEUTICAL DESICCANTS MARKET SHARE, BY COUNTRY, 2020 (% SHARE)
FIGURE 22 COMPETITIVE BENCHMARKING
FIGURE 23 DUPONT DE NEMOURS, INC.: FINANCIAL OVERVIEW
FIGURE 24 DUPONT DE NEMOURS, INC.: SWOT ANALYSIS
FIGURE 25 FILTRATION GROUP CORPORATION: SWOT ANALYSIS
FIGURE 26 SANNER GMBH: SWOT ANALYSIS
FIGURE 27 CLARIANT: FINANCIAL OVERVIEW
FIGURE 28 CLARIANT: SWOT ANALYSIS
FIGURE 29 CSP TECHNOLOGIES, INC.: SWOT ANALYSIS
FIGURE 30 CAPITOL SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 31 DESICCARE, INC.: SWOT ANALYSIS
FIGURE 32 W. R. GRACE & CO: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 W. R. GRACE & CO: SWOT ANALYSIS
FIGURE 34 DESICAN INC.: SWOT ANALYSIS
FIGURE 35 OKER-CHEMIE GMBH: SWOT ANALYSIS